Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome
Authors:
- Jürgen GroetJGJürgen Groet
- Claire MulliganCMClaire Mulligan
- Monica SpinelliMSMonica Spinelli
- Anna SerraASAnna Serra
- Suzanne McElwaineSMSuzanne McElwaine
- Finbarr E. CotterFCFinbarr E. Cotter
- Franca Dagna-BricarelliFDFranca Dagna-Bricarelli
- Giuseppe SaglioGSGiuseppe Saglio
- Giuseppe BassoGBGiuseppe Basso
- Dean NizeticDNDean Nizetic
- 1 September 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (5) , 1887-1888
Abstract
A female DS neonate (patient TMD2 in a previous report2) presented with typical symptoms of TMD; 2 days after birth, a peripheral-blood (PB) sample was taken from which an aliquot was sorted for CD34+ and CD34- blast-cell populations. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis (Figure 1B) detected the full-length GATA1 transcript as well as a shorter transcript lacking exon 2 (spliceΔ-exon 2) in the patient's presentation sample and the CD34- cells, whereas her CD34+ cells lacked the full-length product. Sequencing of the RT-PCR product from the unsorted presentation sample2 revealed a 34-base pair (bp) duplication in GATA1 exon 2. However, cloning of the RT-PCR products revealed additional mutations, each causing translation of a typically truncated6 GATA1 protein. Unsorted and CD34- cells were found to carry 3 different mutations (dup34, ins8, and dup4; Figure 1Ci-iii), which were present on different chromosomes and represent independent clonal proliferations (not shown). CD34+ cells carried spliceΔ-exon 2 as the sole form of GATA1 transcript (Figure 1Civ). Genomic DNA cloning and sequencing from these CD34+ cells revealed the ins8 and dup4 mutations, but not the dup34 mutation (not shown). This was confirmed by PCR amplification from genomic DNA using dup34-allele-specific primers (Figure 1D), which amplified the specific product in the presentation sample but not in CD34+ cells. Therefore, the dup34 of exon 2, a predominant change in the RNA of the presentation sample,2 could only have been contributed by the CD34-, and not CD34+, GATA1-expressing cells.Keywords
This publication has 16 references indexed in Scilit:
- Developmental stage–selective effect of somatically mutated leukemogenic transcription factor GATA1Nature Genetics, 2005
- Origins of leukaemia in children with Down syndromeNature Reviews Cancer, 2005
- CD34 and CD43 Inhibit Mast Cell Adhesion and Are Required for Optimal Mast Cell ReconstitutionImmunity, 2005
- Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndromeBlood, 2004
- Natural history of GATA1 mutations in Down syndromeBlood, 2004
- Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndromeBlood, 2004
- Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorderThe Lancet, 2003
- Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21Blood, 2003
- CD34 is a specific marker of mature murine mast cellsExperimental Hematology, 2002
- Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndromeNature Genetics, 2002